Search Our Blog
- Twitter API is Currently Down.
Above the Crowd
Both Sides of the Table
First Round Capital
Master of 500 Hats
In 2010, the thirtieth year of SoftBank’s existence, its founder Masayoshi Son outlined the company’s vision for the next 30 years. He first set the context by zooming out to talk about how the world and the needs of humanity would evolve over the next 300 years, and stated his firm objective for SoftBank to survive at least that long. And then, zooming back in, explained that in this context, having a 30-year plan was absolutely essential.
There comes a time in the life-span of any large successful company when they consider an IPO. In fact, almost all of the technology companies, which we now consider to be great, such as ASOS, Google and Priceline, have 'gone public' en route to achieving that status.
Now, thanks to a combination of favourable market conditions and the underlying strength of the fundamentals in the technology sector, this is precisely the right moment for the next wave of potentially global businesses to be mulling over and preparing for the possibility of an IPO.
We at Index are leading a $17.5m Series B round into London-based app developer SwiftKey (TouchType Ltd), makers of the best-selling Android app of 2012, the SwiftKey virtual keyboard. We first fell in love with the product, until we met with the team and were blown away by their unique ability to turn their amazing technology into a successful mass-market product.
Comparing the founding of two virtual drug development companies, Funxional Therapeutics in 2006 and XO1 earlier in 2013 proves at least one thing: in just seven years it has become dramatically easier and quicker to create a virtual drug development company. Today it is even possible to take virtual to its logical extreme: a zero person biotech company.
Index Ventures is leading a €2.5m Series A investment alongside Angel investors in Paris-based Rad, a discovery platform for cool fashion, art and design products. Here, Martin Mignot who is joining the Board, explains why we are excited to be working with them…
A tidal wave of technological disruption is rolling through the financial services sector - and not before time, says Jan Hammer, partner at Index Ventures.
Why we decided to back Capitaine Train with €500k of seed capital last year, and to keep supporting them today with a €1.1m contribution to their Series A.
Index Ventures recently completed an $11M Series A investment in XO1, an asset-centric company established with the sole objective of developing the monoclonal antibody Ichorcumab under license from Cambridge University.
If ever there was a case of a demo sealing the deal, then this was it. From the moment we saw Anki Drive cars racing around their track, our minds were made up. Those hundreds of hours I’d spent as a kid, battling electric-powered cars against my friends came flooding back. The Anki team -- who are set to ignite an explosive new category of entertainment experiences, paving the way for a consumer robotics revolution -- had killed it. We were hooked. The deal was all but done.